Connecting You to Tomorrow's Biotechnology Innovations
The challenge with diagnosing chronic traumatic encephalopathy (CTE), a condition that shows up in the overwhelming majority of American football players and other athletes who frequently sustain injuries to the head, is that it can only be diagnosed through an autopsy. Researchers at Medicortex Finland Oy, are working on a diagnostic kit that could detect […]
Researchers at the University of California, Riverside have found that thirdhand-smoke (THS) exposure has a significant effect on health as early as one month after initiation of exposure – an effect that worsens with time. THS results when exhaled smoke and smoke emanating from the tip of burning cigarettes gets on surfaces such as clothing, […]
A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer, according to new research from the Perelman School of Medicine at University of Pennsylvania. Currently over 53,000 people in the United States are diagnosed with pancreatic cancer — the fourth leading cause of cancer death — every […]
Medicortex Finland Oy, a biotechnology company developing a diagnostic kit for brain injury detection based on a medical breakthrough biomarker, recently completed analyzing the results from the first clinical trial. Medicortex is working towards the validation of a Traumatic Brain Injury (TBI) biomarker and incorporating it into a quick and reliable diagnostic kit that can […]
Researchers have made a ground-breaking discovery revealing new molecular information on how the brain regulates depression and anxiety. In so doing, they identified a new molecule that alleviates anxiety and depressive behaviour in rodents. The research, led by Eleanor Coffey, Research Director at Åbo Akademi University in Finland is a collaborative effort between scientists in […]
Patients who have received a solid organ transplant require lifelong immunosuppressive therapy. The threat of transplant rejection due to insufficient drug therapy must be balanced against increased risks of infections and cancer from excessive immunosuppression. A significant unmet need exists for non-invasive diagnostic tools to monitor transplant recipients, especially for early detection of active injury […]
Medicortex Finland Oy (www.medicortex.fi), a biotechnology company developing a diagnostic kit for brain injury based on a medical breakthrough biomarker, recently was granted clearance to begin a clinical trial. The trial will consist of patients that are hospitalized due to a head injury. “Collecting and testing human samples in a clinical trial is a significant […]
To treat or not to treat? That is the question researchers at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) hope to answer with a new advance that could help doctors and their cancer patients decide if a particular therapy would be worth pursuing. Berkeley Lab researchers identified 14 genes regulating genome integrity […]
New research has shown how a cell surface molecule, Lymphotoxin β receptor, controls entry of T-cells into the thymus; and as such presents an opportunity to understanding why cancer patients who undergo bone-marrow transplant are slow to recover their immune system. The study, published in the Journal of Immunology, used mouse models to reveal an […]
People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the August 24, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. “Identifying people who are at risk […]
A team of West Virginia scientists have made a breakthrough in cancer research that could improve the results patients see from lung cancer treatments. Scientists from the West Virginia University Cancer Institute and the Morgantown-based bio-analytic technology company Protea say they’ve identified changes that occur at the molecular level in lung cancer cells. Those changes […]
Cancer cells are notorious for their genomes gone haywire, often yielding fusion proteins — mash-ups of two disparate genes that, once united, assume new and harmful capabilities. Exactly how such genome scrambling impacts RNA, particularly the vast and mysterious world of non-coding RNA, has been largely unexplored. Now, a team led by investigators at Beth […]
Medicortex Finland Oy, a start-up biotechnology company focused on the diagnosis and treatment of neurodegenerative conditions has recently launched a funding round and is seeking investors to help fund research and development of a therapeutic drug and companion diagnostic test for Traumatic Brain Injury (TBI). The company aims to identify a TBI biomarker and, on […]